Submit Deal

SHIONOGI

HQ - Osaka

Summary

Shionogi is a discovery-based pharmaceutical company focused on developing new treatments to improve the lives of patients worldwide.

Deals Overview

Total Deals6

Valued Deals5

Total Value£ 2.81 B

Avg. Deal Size£ 562 M

Market Context

Senior Management

Isao Teshirogi
President and CEO
Nathan McCutcheon
President and CEO, Shionogi Inc
Masahiro Fujita
CFO

Sort

oh-ebashi

HQ - Osaka, Japan

legal advisors (1)

1 Shared Deal

1 For

£ 410 M

Total Value

argot partners

pr advisors (1)

1 Shared Deal

1 Opposite

£ 410 M

Total Value

nomura

HQ - Tokyo

financial advisors (1)

1 Shared Deal

1 Opposite

£ 410 M

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 Opposite

£ 410 M

Total Value

kpmg

HQ - Amstelveen, Netherlands

financial advisors (1)

1 Shared Deal

1 Opposite

£ 410 M

Total Value

morrison foerster

HQ - San Francisco

legal advisors (1)

1 Shared Deal

1 Along

£ 610 M

Total Value

goodwin procter

HQ - Boston

legal advisors (1)

1 Shared Deal

1 Opposite

£ 113 M

Total Value

evercore

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 110 M

Total Value

cleary gottlieb steen & hamilton

HQ - New York

legal advisors (2)

2 Shared Deals

2 For

£ 110 M

Total Value

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

goldman sachs

HQ - New York, United States

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy